Found: 91
Select item for more details and to access through your institution.
Expression of p53 protein isoforms predicts survival in patients with multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 700, doi. 10.1002/ajh.26507
- By:
- Publication type:
- Article
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 5, p. 503, doi. 10.1002/ajh.25758
- By:
- Publication type:
- Article
Patient‐reported health‐related quality of life from the phase III TOURMALINE‐MM1 study of ixazomib‐lenalidomide‐dexamethasone versus placebo‐lenalidomide‐dexamethasone in relapsed/refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 8, p. 985, doi. 10.1002/ajh.25134
- By:
- Publication type:
- Article
Isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma patients with high‐risk cytogenetics: IKEMA subgroup analysis.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 5, p. 504, doi. 10.1111/ejh.13835
- By:
- Publication type:
- Article
Pomalidomide‐dexamethasone for treatment of soft‐tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 5, p. 389, doi. 10.1111/ejh.13217
- By:
- Publication type:
- Article
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials.
- Published in:
- PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0203392
- By:
- Publication type:
- Article
Extramedullary Myeloma Spread Triggered by Surgical Procedures: An Emerging Entity?
- Published in:
- Acta Haematologica, 2014, v. 132, n. 1, p. 36, doi. 10.1159/000354833
- By:
- Publication type:
- Article
Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. 194, doi. 10.1016/j.clml.2023.11.001
- By:
- Publication type:
- Article
Real-World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e341, doi. 10.1016/j.clml.2023.07.006
- By:
- Publication type:
- Article
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. e844, doi. 10.1016/j.clml.2022.04.024
- By:
- Publication type:
- Article
Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. 635, doi. 10.1016/j.clml.2022.04.014
- By:
- Publication type:
- Article
Clinical and Sociodemographic Characteristics of Patients With Relapsed and/or Refractory Multiple Myeloma and Their influence on Treatment in the Real-World Setting in Spain: The CharisMMa Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 4, p. e241, doi. 10.1016/j.clml.2021.10.001
- By:
- Publication type:
- Article
P-217: Isatuximab plus Carfilzomib and Dexamethasone in relapsed Multiple Myeloma patients with high-risk cytogenetics: IKEMA subgroup analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S159, doi. 10.1016/S2152-2650(21)02344-2
- By:
- Publication type:
- Article
P-206: SELECT Trial in Progress: an open-label, phase 2 study of Carfilzomib, Pomalidomide, and Dexamethasone in patients with first or second relapse of Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S152, doi. 10.1016/S2152-2650(21)02333-8
- By:
- Publication type:
- Article
P-179: Immunoparesis remains a negative prognostic factor in newly diagnosed Multiple Myeloma by competing risk analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S135, doi. 10.1016/S2152-2650(21)02306-5
- By:
- Publication type:
- Article
P-169: Outcome of non-transplant eligible patients with newly diagnosed multiple myeloma depending on the eligibility for clinical trials: a single institution experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S128, doi. 10.1016/S2152-2650(21)02296-5
- By:
- Publication type:
- Article
P-124: The history of survival improvement in patients with Multiple Myeloma through real-world data in a 45-year period at a single institution.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S102, doi. 10.1016/S2152-2650(21)02251-5
- By:
- Publication type:
- Article
P-032: Clinical characteristics and outcome of 30 patients with poems syndrome in Catalonia: impact of autologous stem cell transplantation in first line and at relapse.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S55, doi. 10.1016/S2152-2650(21)02166-2
- By:
- Publication type:
- Article
MM-092: Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Elderly Patients with Relapsed Multiple Myeloma: IKEMA Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S420, doi. 10.1016/S2152-2650(21)01942-X
- By:
- Publication type:
- Article
Poster: MM-092: Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Elderly Patients with Relapsed Multiple Myeloma: IKEMA Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S250, doi. 10.1016/S2152-2650(21)01570-6
- By:
- Publication type:
- Article
Single-Cell Characterization of Multiple Myeloma (MM) Immune Microenvironment Identifies CD27-negative T cells as Potential Tumor-Reactive Lymphocytes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e351, doi. 10.1016/j.clml.2019.09.581
- By:
- Publication type:
- Article
Improvement of Early Mortality and Long-Term Survival in Patients With Multiple Myeloma Between 1970 and 2015.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e298, doi. 10.1016/j.clml.2019.09.489
- By:
- Publication type:
- Article
Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma. Impact of disease characteristics, disease status at transplant, and prior number of lines of therapy. Results of retrospective, multicentre Spanish study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e289, doi. 10.1016/j.clml.2019.09.476
- By:
- Publication type:
- Article
Demographic Characteristics and Treatment Patterns of Relapse / Refractory Multiple Myeloma PTS: Charismma Study and Insight MM Registry in Spain.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e257, doi. 10.1016/j.clml.2019.09.425
- By:
- Publication type:
- Article
Outcome of elderly patients with newly diagnosed multiple myeloma depending on the eligibility for clinical trials: a single institution experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e237, doi. 10.1016/j.clml.2019.09.394
- By:
- Publication type:
- Article
New factors involved in the appearance of Mandibular Osteonecrosis by Bisphosphonates in Multiple Myeloma. A multicentric study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e193, doi. 10.1016/j.clml.2019.09.322
- By:
- Publication type:
- Article
Detailed Phenotypic, Molecular and Functional Profiling of Myeloid Derived Suppressor Cells (MDSCs) in the Tumor Immune Micro-Environment (TIME) of Multiple Myeloma (MM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e97, doi. 10.1016/j.clml.2019.09.159
- By:
- Publication type:
- Article
FlowCT: A semi-automated workflow for deconvolution of immunophenotypic data and objective reporting on large datasets.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e94, doi. 10.1016/j.clml.2019.09.153
- By:
- Publication type:
- Article
Integrated Analysis of Bortezomib-Lenalidomide-Dexamethasone vs Bortezomib-Thalidomide-Dexamethasone in Transplant-Eligible Newly Diagnosed Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e1, doi. 10.1016/j.clml.2019.09.002
- By:
- Publication type:
- Article
Bone Marrow Plasma Cell Infiltration in Light-Chain Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S236, doi. 10.1016/j.clml.2018.07.122
- By:
- Publication type:
- Article
Impact of Evolving Pattern in Early Progression of Patients With Smoldering Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e23, doi. 10.1016/j.clml.2017.03.040
- By:
- Publication type:
- Article
Plasmacytomas in Multiple Myeloma: 45-Years Experience from a Single Institution.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e107, doi. 10.1016/j.clml.2017.03.194
- By:
- Publication type:
- Article
Efficacy of Novel Agents on Soft-tissue Plasmacytomas in Patients with Relapsed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e128, doi. 10.1016/j.clml.2017.03.232
- By:
- Publication type:
- Article
Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Acquired Fanconi Syndrome Secondary to Monoclonal Gammopathies: A Case Series From a Single Center.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 5, p. 614, doi. 10.1016/j.clml.2013.04.008
- By:
- Publication type:
- Article
Increased collection efficiency of CD34+ cells after mobilization with preemptive use of plerixafor followed by leukocytapheresis on the same day.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and safety of one-day offline extracorporeal photopheresis schedule processing one total blood volume for treating patients with graft-versus-host disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Lymphoplasmacytic lymphoma causing light chain cast nephropathy.
- Published in:
- Nephrology Dialysis Transplantation, 2012, v. 27, n. 1, p. 450, doi. 10.1093/ndt/gfr730
- By:
- Publication type:
- Article
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00805-x
- By:
- Publication type:
- Article
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00730-5
- By:
- Publication type:
- Article
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00652-2
- By:
- Publication type:
- Article
Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00647-z
- By:
- Publication type:
- Article
Extramedullary disease in multiple myeloma: a systematic literature review.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00643-3
- By:
- Publication type:
- Article
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00587-0
- By:
- Publication type:
- Article
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00490-8
- By:
- Publication type:
- Article
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 10, p. 1, doi. 10.1038/s41408-020-00377-0
- By:
- Publication type:
- Article
The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 1, p. 46, doi. 10.1111/j.1365-2141.2008.07303.x
- By:
- Publication type:
- Article
Comparative genomic hybridisation identifies two variants of smoldering multiple myeloma.
- Published in:
- British Journal of Haematology, 2005, v. 130, n. 5, p. 729, doi. 10.1111/j.1365-2141.2005.05673.x
- By:
- Publication type:
- Article
Limitations of Gallium-67 SPECT in histological transformation of chronic lymphocytic leukaemia: an analysis of 13 patients with clinically suspected Richter's syndrome.
- Published in:
- British Journal of Haematology, 2002, v. 119, n. 2, p. 484, doi. 10.1046/j.1365-2141.2002.03788.x
- By:
- Publication type:
- Article